Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Scientific Reports|June 22, 2019
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy SamplesAna Vivancos, Enrique Aranda, Manuel Benavides, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 1, 2005
Pseudomembranous colitis associated with chemotherapy with 5-fluorouracilRafael Morales Chamorro, Raquel Serrano Blanch, María José Méndez Vidal, et al.
Cancers|July 9, 2022
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus BevacizumabM José Ortiz-Morales, Marta Toledano-Fonseca, Rafael Mena-Osuna, et al.
Breast (Edinburgh, Scotland)|November 29, 2007
Time-to-progression in breast cancer: a stratification model for clinical trialsJuan de la Haba-Rodríguez, Enrique Aranda, Antonio Llombart, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2020
Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I resultsAlfredo Carrato, José María Vieitez, Manuel Benavides, et al.
Medicina Clinica|December 26, 2017
Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose ([<sup>18</sup>F] FDG) in the detection of recurrent ovarian cancerAzahara Palomar Muñoz, José Manuel Cordero García, Prado Talavera Rubio, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 18, 2008
Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007Juan de la Haba-Rodríguez, Emilio Alba, Agustí Barnadas, et al.
Plos One|June 25, 2015
Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cellsAraceli Valverde, Jon Peñarando, Amanda Cañas, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 2, 2020
Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cellsLaura M López-Sánchez, Rafael Mena, Silvia Guil-Luna, et al.
Cancer Investigation|June 18, 2004
Comparative study of the immunohistochemical phenotype in breast cancer and its lymph node metastatic locationJuan R De la Haba-Rodríguez, Manuel Ruiz Borrego, Auxiliadora Gómez España, et al.
Pageof 15